Can bacteriophage therapy replace antibiotics for resistant infections?

Where does phage therapy work best?

Phage therapy is most effective against multidrug-resistant (MDR) bacteria that no longer respond to standard antibiotics. In one study, a phage called vB_BpP_HN01 killed 24 out of 25 clinical isolates of Burkholderia pseudomallei—the bacterium that causes melioidosis—and improved survival in infected roundworms from near-certain death to 90% [1]. Similarly, a 2024 review on drug-resistant Staphylococcus aureus infections found that phages can successfully treat bacteremia (blood infections) and other hard-to-treat infections, though the evidence still comes mostly from animal models and individual patient cases rather than large trials [3].

Phages also excel at penetrating biofilms—slimy bacterial communities that antibiotics struggle to reach. A 2024 review explains that phage enzymes can break down the sticky substances that form biofilms, making hidden bacteria vulnerable to both phages and antibiotics [7]. This is especially useful for chronic infections like those in cystic fibrosis patients or on medical devices, where biofilms are a major problem [4][10].

Is it better to use phages alone or with antibiotics?

The strongest evidence points to combining phages with antibiotics rather than using either alone. In the melioidosis study, combining the phage with antibiotics boosted the survival of infected human lung cells to 96.8%, compared to 70.6% with the phage alone [1]. A 2023 review of combination therapy found that most studies reported positive outcomes when phages and antibiotics were used together, though a few combinations showed no benefit [8]. The synergy works because phages can break down bacterial defenses (like biofilms) and make the bacteria more sensitive to antibiotics, while antibiotics kill bacteria that might otherwise evolve resistance to the phage [5][11].

This approach is already being tested in humans. A systematic review of seven randomized controlled trials (RCTs) covering 418 patients found that phage therapy was safe—only 5.1% of patients had mild side effects—and three of those trials showed statistically significant improvements in outcomes like wound healing or reduced diarrhea compared to standard care or placebo [2]. However, the same review notes that study designs were limited, making it hard to draw firm conclusions about how well phage-antibiotic combinations work across different infections [2].

Why isn't phage therapy widely available yet?

Despite its promise, phage therapy faces major practical barriers. A 2025 review of clinical lab challenges in the U.S. highlights that there are no standard methods for testing which phages work against a patient's specific bacteria, no approved quality controls, and no clear regulatory pathway for approving phage treatments [6]. This means each treatment often has to be custom-made for an individual patient, which is slow and expensive. As one expert opinion piece puts it, 'It is not likely that phages will replace antibiotics'—instead, they will be a valuable tool for MDR infections, while antibiotics remain the mainstay for most infections [9].

Another challenge is that bacteria can evolve resistance to phages, just as they do to antibiotics. However, because phages are so specific, they can be swapped or engineered to overcome this resistance. A 2025 review notes that advances in genetic engineering allow scientists to create 'phage cocktails' (mixtures of multiple phages) or modify phages to target resistant bacteria more effectively [12]. Still, until manufacturing is standardized and large-scale clinical trials confirm the best doses and delivery methods, phage therapy will remain a last-resort option in most countries [13][11].

About These Sources

This answer is built on 13 peer-reviewed studies — published from 2022 to 2026, 9 from 2024 or later, 6 in Q1 journals, collectively cited 660 times — selected as the most relevant from 14 studies that passed quality screening, drawn from 66 papers retrieved from a database of over 500 million.

Sources used in this answer

Related research questions